Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
06/2002
06/11/2002US6403604 Nitrogen-based camptothecin derivatives
06/11/2002US6403597 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
06/11/2002US6403573 Compounds of azetidine and pyrrolidin
06/11/2002US6403361 Enzymatic method for modification of recombinant polypeptides
06/11/2002US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics
06/11/2002US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease
06/11/2002CA2239705C Quinazoline-4-one ampa antagonists
06/11/2002CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
06/06/2002WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002WO2002044320A2 Human elongase genes and uses thereof
06/06/2002WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists
06/06/2002WO2002044172A1 Morpholine derivatives as antagonists of orexin receptors
06/06/2002WO2002044165A1 Quinoline derivatives as nk-3 antagonists
06/06/2002WO2002044142A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
06/06/2002WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
06/06/2002WO2002043807A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
06/06/2002WO2002043766A1 Medicinal compositions and process for producing the same
06/06/2002WO2002043648A2 Compounds active at the glucocorticoid receptor ii
06/06/2002WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE
06/06/2002WO2001090334A3 Drug metabolizing enzymes
06/06/2002WO2001080860A3 Daily treatment for erectile dysfunction using a pde5 inhibitor
06/06/2002WO2001079442A3 Albumin fusion proteins
06/06/2002WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/06/2002WO2001044207B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
06/06/2002WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
06/06/2002US20020068765 8,9-dihydro-7H-benzocycloheptene derivatives are useful for phophylaxis and therapy of osteoporosis(have selective estrogenic activity on bones)
06/06/2002US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives
06/06/2002US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof
06/06/2002US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc.
06/06/2002US20020068735 Progesterone receptor antagonist; inhibiting breast, uterine, ovarian, endometrial, or prostate cancer
06/06/2002US20020068319 32 human secreted proteins
06/06/2002US20020068100 Combination therapy for premenstrual symptoms
06/06/2002DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines
06/06/2002CA2430924A1 Angiotensin receptor antagonist composition for the treatment of sexual dysfunction associated with hypertension and another condition
06/06/2002CA2430311A1 Compounds active at the glucocorticoid receptor ii
06/06/2002CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002CA2429469A1 Human elongase genes and uses thereof
06/05/2002EP1211313A2 Modulation of PDE11A activity
06/05/2002EP1211247A1 Acylamino cyclopropane derivatives
06/05/2002EP1210951A2 Combination for treating andropause containing estrogen agonists/antagonists and testosterone
06/05/2002EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor
06/05/2002EP1210419A2 Human transmembrane proteins
06/05/2002EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES
06/05/2002EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
06/05/2002EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands
06/05/2002EP1210132A1 Herb medicine composition to be contained in sanitary materials for infants
06/05/2002EP1210115A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES
06/05/2002EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation
06/05/2002EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress
06/05/2002EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease
06/05/2002EP1209986A1 Metal-containing compositions, preparations and uses
06/05/2002EP1117420B1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues
06/05/2002EP0851855B1 Acylated derivatives of melatonin and its analogues, useful as medicaments
06/05/2002EP0684825B1 Kit for preventing or inhibiting fertilization
06/05/2002EP0627914B1 Use of butylurea as contraceptive agent
06/05/2002CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV
06/05/2002CN1352566A Gonadotrophins
06/05/2002CN1352557A Compositions for improivng fertility
06/05/2002CN1352545A 吲哚衍生物 Indole derivatives
06/04/2002US6399826 Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
06/04/2002US6399780 Kinase inhibitors; anticancer agents
06/04/2002US6399778 Crystalline solvate
06/04/2002US6399634 Benzothiophene compounds, compositions, and methods
06/04/2002US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists
06/04/2002US6399618 Compositions and methods for modulating sexual activity
06/04/2002US6399593 Contraceptives
06/04/2002US6399072 Reverse addiction with isoflavones, lignans, sapoins, catechins and phenol acids
06/04/2002CA2364108A1 Acylamino cyclopropane derivatives
05/2002
05/30/2002WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/30/2002WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
05/30/2002WO2002042332A2 Truncated cd200
05/30/2002WO2002042302A1 Novel sulfonamide-substituted pyrazolopyridine derivatives
05/30/2002WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives
05/30/2002WO2002042300A1 Novel carbamate-substituted pyrazolopyridine derivatives
05/30/2002WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives
05/30/2002WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002041903A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
05/30/2002WO2002041896A2 Use of thienopyrimidines
05/30/2002WO2002041894A2 Selective dopamine d4 receptor agonists for treating sexual dysfunction
05/30/2002WO2002041883A2 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
05/30/2002WO2002041880A2 Use of pyrazolo[4,3-d]pyrimidines
05/30/2002WO2002041835A2 Estrogen receptor modulators
05/30/2002WO2002020736A9 Proteases
05/30/2002WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
05/30/2002WO2002000254A3 Materials and methods relating for the treatment and diagnosis of pre-eclampsia
05/30/2002WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
05/30/2002WO2001085149A3 Felbamate derived compounds
05/30/2002WO2000066581A8 Cyanopyrroles as progesterone receptor agonists
05/30/2002WO2000066225A8 Contraceptive compositions containing cyclic carbamates and amide derivatives
05/30/2002US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc.
05/30/2002US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors
05/30/2002US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases
05/30/2002US20020065289 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
05/30/2002US20020065284 Dipeptide derivatives
05/30/2002US20020065277 Administering to an obese patient or a patient at risk of becoming obese therapeutically effective amount of compound that attenuates binding of agouti-related protein to melanocortin receptors
05/30/2002US20020065257 17beta-amino and hydroxylamino-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/30/2002US20020065226 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
05/30/2002US20020064856 Novel proteases
05/30/2002US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy